CN108403700A - 一种牛呼吸道疾病治疗用复合注射液 - Google Patents

一种牛呼吸道疾病治疗用复合注射液 Download PDF

Info

Publication number
CN108403700A
CN108403700A CN201810600310.5A CN201810600310A CN108403700A CN 108403700 A CN108403700 A CN 108403700A CN 201810600310 A CN201810600310 A CN 201810600310A CN 108403700 A CN108403700 A CN 108403700A
Authority
CN
China
Prior art keywords
vitamin
respiratory disease
injection
cattle
disease treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810600310.5A
Other languages
English (en)
Inventor
彭安业
胡建军
张迎春
邓林涛
朱广艺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinjiang Production And Construction Corps First Division Animal Husbandry And Veterinary Workstation
Tarim University
Original Assignee
Xinjiang Production And Construction Corps First Division Animal Husbandry And Veterinary Workstation
Tarim University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinjiang Production And Construction Corps First Division Animal Husbandry And Veterinary Workstation, Tarim University filed Critical Xinjiang Production And Construction Corps First Division Animal Husbandry And Veterinary Workstation
Priority to CN201810600310.5A priority Critical patent/CN108403700A/zh
Publication of CN108403700A publication Critical patent/CN108403700A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种牛呼吸道疾病治疗用复合注射液，每1000ml注射液含有：头孢丙烯450～550g、磺胺间甲氧嘧啶100～300g、甘草酸二钾1～5g、地塞米松磷酸钠33～50mg、维生素B1 0.15～0.35g、维生素B2 0.17～0.23g、维生素C 0.6～1g,余量为注射用水。本发明抗菌谱较广，抗菌效力较强，可有效治疗牛呼吸道疾病，且可提高病牛的抵抗力，缩短病程。

Description

一种牛呼吸道疾病治疗用复合注射液
技术领域
本发明涉及畜牧领域，具体涉及一种牛呼吸道疾病治疗用复合注射液。
背景技术
牛呼吸道疾病综合征一般由于感染呼吸道合胞体病毒、支原体、甲型流感病毒、牛巴氏杆菌、牛疱疹病毒1型等其中单独一种病原或者几种病原混合而引起，对养牛业的健康发展具有严重的危害。该病主要是对育肥肉牛、犊牛以及奶牛产生较大危害，以发病率和死亡率较高为主要特征，发生后通常会严重损害养殖户的经济损失。
发明内容
本发明的目的在于提供一种牛呼吸道疾病治疗用复合注射液，抗菌谱较广，抗菌效力较强，可有效治疗牛呼吸道疾病，且可提高病牛的抵抗力，缩短病程。
为实现上述目的，本发明采取的技术方案为：
一种牛呼吸道疾病治疗用复合注射液，每1000ml注射液含有：
头孢丙烯450～550g、磺胺间甲氧嘧啶100～300g、甘草酸二钾1～5g、地塞米松磷酸钠33～50mg、维生素B1 0.15～0.35g、维生素B2 0.17～0.23g、维生素C 0.6～1g,余量为注射用水。
优选地，每1000ml注射液含有：
头孢丙烯450g、磺胺间甲氧嘧啶100g、甘草酸二钾1g、地塞米松磷酸钠33mg、维生素B1 0.15g、维生素B2 0.17g、维生素C 0.6g,余量为注射用水。
优选地，每1000ml注射液含有：
头孢丙烯550g、磺胺间甲氧嘧啶300g、甘草酸二钾5g、地塞米松磷酸钠50mg、维生素B1 0.35g、维生素B2 0.23g、维生素C 1g,余量为注射用水。
优选地，每1000ml注射液含有：
头孢丙烯500g、磺胺间甲氧嘧啶200g、甘草酸二钾3g、地塞米松磷酸钠41.5mg、维生素B1 0.2g、维生素B2 0.2g、维生素C 0.8g,余量为注射用水。
本发明具有以下有益效果：
抗菌谱较广，抗菌效力较强，可有效治疗牛呼吸道疾病，且可提高病牛的抵抗力，缩短病程。
具体实施方式
为了使本发明的目的及优点更加清楚明白，以下结合实施例对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
实施例1
一种牛呼吸道疾病治疗用复合注射液，每1000ml注射液含有：
头孢丙烯450g、磺胺间甲氧嘧啶100g、甘草酸二钾1g、地塞米松磷酸钠33mg、维生素B1 0.15g、维生素B2 0.17g、维生素C 0.6g,余量为注射用水。
实施例2
一种牛呼吸道疾病治疗用复合注射液，每1000ml注射液含有：
头孢丙烯550g、磺胺间甲氧嘧啶300g、甘草酸二钾5g、地塞米松磷酸钠50mg、维生素B1 0.35g、维生素B2 0.23g、维生素C 1g,余量为注射用水。
实施例3
一种牛呼吸道疾病治疗用复合注射液，每1000ml注射液含有：
头孢丙烯500g、磺胺间甲氧嘧啶200g、甘草酸二钾3g、地塞米松磷酸钠41.5mg、维生素B1 0.2g、维生素B2 0.2g、维生素C 0.8g,余量为注射用水。应用例
试验时间：2017.03.18日，试验牛群，某养殖厂育肥牛，60头，分为4组，对照组，试验组，常规治疗I组，常规治疗II组每组15只，用法用量：治疗组肌内注射一次量每1kg体重0.5ml，一日一次，仅用一次。
对照组：为空白组，不使用任何药物治疗。
实验组：为注射液治疗组。1kg体重0.5ml
常规治疗A组：为市售药物治疗组，麻杏石甘注射液，1kg体重0.5ml。
常规治疗B组：为市售药物治疗组,氟苯尼考注射液20％，1kg体重0.5ml。
试验结果如下：
以上所述仅是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明原理的前提下，还可以作出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。

Claims (4)

1.一种牛呼吸道疾病治疗用复合注射液，其特征在于：每1000ml注射液含有：
头孢丙烯450～550g、磺胺间甲氧嘧啶100～300g、甘草酸二钾1～5g、地塞米松磷酸钠33～50mg、维生素B1 0.15～0.35g、维生素B2 0.17～0.23g、维生素C 0.6～1g,余量为注射用水。
2.如权利要求1所述的一种牛呼吸道疾病治疗用复合注射液，其特征在于：每1000ml注射液含有：
头孢丙烯450g、磺胺间甲氧嘧啶100g、甘草酸二钾1g、地塞米松磷酸钠33mg、维生素B10.15g、维生素B2 0.17g、维生素C 0.6g,余量为注射用水。
3.如权利要求1所述的一种牛呼吸道疾病治疗用复合注射液，其特征在于：每1000ml注射液含有：
头孢丙烯550g、磺胺间甲氧嘧啶300g、甘草酸二钾5g、地塞米松磷酸钠50mg、维生素B10.35g、维生素B2 0.23g、维生素C 1g,余量为注射用水。
4.如权利要求1所述的一种牛呼吸道疾病治疗用复合注射液，其特征在于：每1000ml注射液含有：
头孢丙烯500g、磺胺间甲氧嘧啶200g、甘草酸二钾3g、地塞米松磷酸钠41.5mg、维生素B1 0.2g、维生素B2 0.2g、维生素C 0.8g,余量为注射用水。
CN201810600310.5A 2018-06-12 2018-06-12 一种牛呼吸道疾病治疗用复合注射液 Pending CN108403700A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810600310.5A CN108403700A (zh) 2018-06-12 2018-06-12 一种牛呼吸道疾病治疗用复合注射液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810600310.5A CN108403700A (zh) 2018-06-12 2018-06-12 一种牛呼吸道疾病治疗用复合注射液

Publications (1)

Publication Number Publication Date
CN108403700A true CN108403700A (zh) 2018-08-17

Family

ID=63141620

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810600310.5A Pending CN108403700A (zh) 2018-06-12 2018-06-12 一种牛呼吸道疾病治疗用复合注射液

Country Status (1)

Country Link
CN (1) CN108403700A (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376054A (zh) * 1999-09-24 2002-10-23 爱尔康公司 含环丙沙星和地塞米松的局部悬浮制剂
CN1579404A (zh) * 2003-08-06 2005-02-16 孙明杰 甘草甜素新制剂
CN101822688A (zh) * 2010-05-19 2010-09-08 陈建波 兽用复方泰乐菌素注射液及其制备方法
CN103550226A (zh) * 2013-11-12 2014-02-05 崔合芳 一种复方磺胺间甲氧嘧啶钠注射液及其制备方法
CN104208076A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 一种含有头孢类抗生素、糖皮质激素的复方的吸入制剂

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376054A (zh) * 1999-09-24 2002-10-23 爱尔康公司 含环丙沙星和地塞米松的局部悬浮制剂
CN1579404A (zh) * 2003-08-06 2005-02-16 孙明杰 甘草甜素新制剂
CN101822688A (zh) * 2010-05-19 2010-09-08 陈建波 兽用复方泰乐菌素注射液及其制备方法
CN104208076A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 一种含有头孢类抗生素、糖皮质激素的复方的吸入制剂
CN103550226A (zh) * 2013-11-12 2014-02-05 崔合芳 一种复方磺胺间甲氧嘧啶钠注射液及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘德成等: "《临床兽医基础》", 31 July 2014 *
方炳虎等: "《现代兽医兽药大全 动物常用中药与化药分册》", 30 November 2014 *

Similar Documents

Publication Publication Date Title
US20090304813A1 (en) Virucidal compositions and uses
CN101468032A (zh) 一种用于治疗畜禽呼吸系统疾病的可溶性粉
CN101972226B (zh) 一种兽用盐酸多西环素注射液及其制备方法
CN105125574A (zh) 聚六亚甲基胍畜禽药物粉剂的配方及其制备工艺
MX2021009219A (es) Triamtereno o nolatrexed para su uso en el tratamiento de la fenilcetonuria.
CN101450067A (zh) 一种用于防治畜禽呼吸道疾病的预混剂
CN108403700A (zh) 一种牛呼吸道疾病治疗用复合注射液
CN102784159B (zh) 兽用注射用复方增效酒石酸泰乐菌素
CN107617102A (zh) 一种治疗鸡球虫病的中药添加剂组合物
CN102793713A (zh) 盐酸林可霉素-硫酸大观霉素注射液及其制备方法
CN103230583A (zh) 兽用治疗肠道疾病的烟酸诺氟沙星复方注射液及制备方法
CN102000092B (zh) 磺胺嘧啶钠在制备预防或治疗家蚕败血病药物中的用途
CN101829129B (zh) 兽用复方硫酸庆大霉素注射液及其制备方法
CN101199520A (zh) 含丙磺舒的兽用β-内酰胺类抗生素复方制剂
RU2739112C1 (ru) Препарат для лечения и профилактики субклинического мастита у коров
DE102006032233A1 (de) Eukalyptol und Menthol enthaltende Zubereitung
DE3153623C2 (zh)
CN101966197A (zh) 用于治疗牛严重复合型寄生虫感染的组合物及制备方法
CN104147046B (zh) 一种用于治疗家畜外伤及感染的喷雾剂及其制备方法
CN103830254A (zh) 一种用于治疗畜禽呼吸系统疾病的可溶性粉
CN102973583B (zh) 治疗家禽腹泻的复方硫酸庆大霉素组合物及其制备方法
CN102784158B (zh) 兽用注射用复方增效酒石酸泰乐菌素的制备方法
RU2452193C2 (ru) Способ кормления телят
RU2251267C1 (ru) Инсектицидный состав для борьбы с личинками оводов эга-2
CA3242451A1 (en) An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180817